164 research outputs found
Analysis of heat transfer in different CPC solar collectors: A CFD approach
In this paper a methodology is proposed to estimate thermal heat losses inside compound parabolic collectors (CPC) to be used in designing and validating new collectors' concepts and materials. CFD simulations were carried out on different CPCs, taking into account the effective working conditions and the presence of radiative heat transfer as well as the absence of adiabatic walls. The CFD model was validated considering a previous work reported in literature. The results were employed to develop some correlations by interpolation of numerical data, to express the Nusselt number on the receiver. We used these correlations to calculate heat losses of the receiver and to show the influence of different parameters such as the shape of receiver itself, tilt angle and concentration ratio. The variation of terms of the correlation as a function of characteristic length and concentration was studied. These results might be employed for a preliminary estimation procedure of a CPC collector efficiency and to propose sizing criteria of general validity for this class of devices
Trading-Off Machine Learning Algorithms towards Data-Driven Administrative-Socio-Economic Population Health Management
Together with population ageing, the number of people suffering from multimorbidity is increasing, up to more than half of the population by 2035. This part of the population is composed by the highest-risk patients, who are, at the same time, the major users of the healthcare systems. The early identification of this sub-population can really help to improve people’s quality of life and reduce healthcare costs. In this paper, we describe a population health management tool based on state-of-the-art intelligent algorithms, starting from administrative and socio-economic data, for the early identification of high-risk patients. The study refers to the population of the Local Health Unit of Central Tuscany in 2015, which amounts to 1,670,129 residents. After a trade-off on machine learning models and on input data, Random Forest applied to 1-year of historical data achieves the best results, outperforming state-of-the-art models. The most important variables for this model, in terms of mean minimal depth, accuracy decrease and Gini decrease, result to be age and some group of drugs, such as high-ceiling diuretics. Thanks to the low inference time and reduced memory usage, the resulting model allows for real-time risk prediction updates whenever new data become available, giving General Practitioners the possibility to early adopt personalised medicine
LaserCube optical communication terminal for nano and micro satellites
This paper presents the design and testing of LaserCube, a miniature optical communication terminal conceived for nano and microsatellites. The system architecture has been designed for both the downlink and intersatellite link version of the system. Then, a complete engineering model of LaserCube in its intersatellite link configuration has been developed and tested. It features (1) a dual stage pointing and tracking system based on a coarse pointing mechanism patented by Stellar Project, (2) an optical head with a full-duplex telecom channel with transmission and reception on the same wavelength for two-way links, (3) a transceiver section with telecom laser source and optical receiver and (4) the terminal control unit with onboard computer, actuator drivers and data interface. Experimental validation of the system is achieved through a laboratory simulation of an intersatellite link scenario with realistic dynamic disturbance coming from the host satellite attitude jitter
Mortality Risk Associated with Diabetic Foot Complications in People with or without History of Diabetic Foot Hospitalizations
The aim of this study was to evaluate the risk of death after hospitalizations for diabetic foot (DF) complications, comparing two different cohorts of people with or without a prior history of DF hospitalizations across the years 2011 to 2018 in Tuscany, Italy. The DF complications were categorized by administrative source datasets such as: amputations (both major and minor), gangrene, ulcers, infections, Charcot and revascularizations. A further aim was to present the trend over time of the first ever incidents of diabetic foot hospitalizations in Tuscany. The eight-year-mortality rate was higher in the cohort with prior hospitalizations (n = 6633; 59%) compared with the cohort with first incident DF hospitalizations (n = 5028; 44%). Amputations (especially major ones) and ulcers had the worst effect on survival in people without basal history of DF hospitalizations and respectively in those with a history of prior DF hospitalizations. In both cohorts, revascularization procedures, when compared to ulcers, were associated with a significantly reduced risk of mortality. The prevalence rate of minor amputations showed a slightly rising trend over time. This result agrees with the national trend. Conversely, the progressive increase over time of revascularizations, associated with the fractional decrease in the rate of gangrene, suggests a trend for more proactive behavior by DF care teams in Tuscany
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy)
Objective Chronic comorbidities are common in people with multiple sclerosis (PwMS), thus worsening their prognosis and quality of life, and increasing disease burden. The aim of the present study was to evaluate the prevalence of common comorbidities in PwMS in Tuscany (Central Italy) and to compare it with the general population. Methods The prevalence of comorbidities, including diabetes, chronic obstructive pulmonary disease (COPD), hypertension, stroke, heart failure (HF), cardiac infarction and ischemic heart disease (IHD), was assessed in PwMS and in general population resident in Tuscany, aged > 20 years, using administrative data. Results In total, we identified 8,274 PwMS. Among them, 34% had at least one comorbidity, with hypertension being the most common (28.5%). Comparing PwMS with the general population, PwMS had a higher frequency of hypertension and stroke when considering the whole group, and of diabetes, COPD, and IHD when considering sex and age subgroups. This increased risk was especially evident in the young and intermediate age groups, where multiple sclerosis may play an important role as risk factor for some comorbidities. In PwMS, as well as in the general population, prevalence of chronic diseases was higher in males and increased with age. Conclusions Comorbidities frequently coexist with multiple sclerosis and they may have an impact on this complex disease, from the health, clinical, and socioeconomic points of view. Therefore, a routine screening of chronic comorbidities should be a crucial step in clinical practice, as well as the promotion of healthy lifestyles to prevent the onset and to reduce their burden
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi
INTRODUZIONE
L’Italia è un’area ad elevato rischio di sclerosi multipla (SM) con una prevalenza stimata di 110.000 casi e un’incidenza di 3.400 casi annui [1]. Gli ultimi dati pubblicati sulla prevalenza sono 149 casi su 100.000 a Genova nel 2007 [2], 140 casi a Padova nel 2009 [3] e 210 nella parte meridionale della Sardegna nel 2007 [4]. Per quanto riguarda l’incidenza, i dati più recenti sono 5,5 casi su 100.000 a Padova nel periodo 2000-09 [3], 6,6 a Genova nel 1998-2007 [2], e 9,7 in Sardegna nel 2003-07 [4]. Dallo scorso anno è stato attivato in Italia un registro nazionale di SM il quale rappresenterà , nel prossimo futuro, un valido strumento per lo studio dell’epidemiologia di questa malattia. Anche in Toscana è presente, dal 2006, un registro regionale della SM ma, al momento, non è rappresentativo dell’intera popolazione di pazienti. Una possibile alternativa per studiare l’epidemiologia è attraverso i dati amministrativi. Questi, infatti, coprono l’intera popolazione residente e vengono raccolti di routine in un modo standardizzato ai fini della gestione del servizio sanitario. In un precedente lavoro, abbiamo creato e validato un algoritmo di cattura dei casi prevalenti basato su fonti amministrative [5]. La prevalenza, calcolata al 2011, è risultata pari a 188 casi per 100.000 [5]. Anche altre Regioni hanno utilizzato i dati amministrativi per stimare la prevalenza della SM, come il Lazio con 131 casi su 100.000 nel 2011 [6], la Puglia con 183 casi nel 2012, il Veneto con 170-180 casi nel 2015, la Sicilia con 110 casi nel 2010 e la Sardegna con 360 casi nel 2016 [1].
OBIETTIVI
Calcolare l’incidenza della SM in Toscana utilizzando dati amministrativi.
METODI
Per il calcolo dell’incidenza abbiamo creato il seguente algoritmo: ospedalizzazione in reparto per acuti e con diagnosi primaria di SM, esenzione attiva per SM, e prescrizione di farmaci specifici. I casi incidenti sono stati identificati come quei casi catturati dall’algoritmo non tracciati in precedenza nei flussi amministrativi, e la data della prima traccia è stata considerata quale data di diagnosi della SM. Da questa coorte di soggetti abbiamo selezionato i pazienti con un’età ≤ 55 anni, residenti in Toscana al momento della diagnosi e presenti in anagrafe da almeno 10 anni (o nati in Toscana se età <10). Abbiamo calcolato i tassi grezzi e standardizzati e gli intervalli di confidenza (IC) al 95% per gli anni 2011-2015.
RISULTATI
Abbiamo identificato, dal 2011 al 2015, 1.056 nuovi casi in Toscana con un’incidenza che varia da 5,04 nel 2011 a 6,02 casi su 100.000 nel 2015 (Tabella 1). Nelle donne l’incidenza è circa due volte più alta rispetto agli uomini con un range che va da 6,48 nel 2011 a 7,96 su 100.000 nel 2015 nelle donne, e da 3,49 nel 2011 a 3,93 nel 2015 negli uomini (Tabella 2). Prendendo in considerazione l’ultimo anno di analisi (2015), abbiamo inoltre osservato delle differenze per ASL di residenza al momento della diagnosi, con aree in cui il tasso di incidenza è inferiore alla media regionale, come Grosseto (4,58), Pisa (4,33 casi/100.000), Siena (3,30), Lucca (3,07) e Viareggio (3,06), e aree in cui l’incidenza è più elevata rispetto alla media, come Empoli (7,99), Livorno (8,80) e Arezzo (9,78)
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data
AIMS
Italy is a high-risk area for Multiple Sclerosis (MS) with a prevalence of around 140/105 (2009) with the exception of Sardinia, with about 224 cases/105 (2009). Nowadays, in Italy, prevalence is absolutely higher than the above estimates. Indeed, prevalence is rising due to annual incidence that is higher than annual mortality. In Tuscany a population MS register has been founded but, to date, it’s not yet completed. To monitor disease epidemiology, comorbidities and care pathways, but also to describe the disease burden and to plan its prevention, treatment and management strategies and resource allocation, population-based studies are preferable. Administrative data offer a unique opportunity for population-based prevalence study of chronic diseases such as MS.
Our aim is to update the prevalence of MS in Tuscany and to demonstrate its progressive increment.
METHODS
The prevalence was calculated using a case-finding algorithm based on administrative data: hospitalization, specific MS drug dispensing, disease-specific exemptions from patient copayment, home and residential long-term care and inhabitant registry. To test algorithm sensitivity, we used a true-positive reference cohort of 302 MS patients from the Tuscan MS register. To test algorithm specificity, we used a general population cohort of 2,644,094 individuals who were presumably not affected by MS (who had never effectuated either cranial or spinal cord CT scan or MRI and had never received a neurological outpatient visit within the NHS). We calculated prevalence on three consecutive years (2011, 2012, 2013).
RESULTS
At prevalence date (31 December), we identified 6,890 cases in 2011, 7,057 in 2012 and 7,330 in 2013 with a rate of 187.9, 191.1 and 195.4/105, respectively. The female:male ratio slightly increased from 2.0 in 2011 to 2.1 in 2012-2013. The sensitivity of algorithm was 98% and its specificity was 99.99%.
DISCUSSION
We found a progressive increment of prevalence that confirmed our hypothesis of increasing prevalence. Although our validity study demonstrated a high level of sensibility, we could miss some patients, especially individuals with a severe MS, who did not access the healthcare system and who did not use the DMDs included in our algorithm.
CONCLUSIONS
We confirmed that Tuscany is a high-risk area for MS and that the prevalence is increasing over time. Despite some limitations, we also demonstrated that our algorithm can accurately identify patients and this cohort is suitable to monitor care pathways. Our future aim is to create an integrated dataset with administrative and clinical data from MS register
The impact of different rehabilitation strategies after major events in the elderly: the case of stroke and hip fracture in the Tuscany region
<p>Abstract</p> <p>Background</p> <p>On a regional level, our aims were to describe rehabilitation patterns for elderly patients with stroke and hip fracture and to investigate mortality risk during the 6-month post acute period.</p> <p>Methods</p> <p>Data sources included administrative data relative to patients aged 65+ resident in Tuscany admitted in hospital for stroke or hip fracture between 2001 and 2003, traced up to 3 years before and 6 months following index admission. The study design involves computerized linkage of administrative data, and an exploratory analysis of the association between rehabilitation patterns and 6-month mortality, adjusting for clinical, demographic, and acute-related care characteristics using multivariate Cox regression.</p> <p>Results</p> <p>Rehabilitation patterns vary greatly across Tuscany with considerable cost implications. Six month mortality risk for stroke patients is significantly lower among residents of Local Health Authorities where patients are more frequently rehabilitated, specifically in extra-hospital settings.</p> <p>Conclusion</p> <p>Our study, targeting two crucial conditions for elderly patients, found a high variability of rehabilitation patterns across a region, albeit coherent between the two pathologies, associated with remarkable differences in average expenditure. Differences in hazard rates for 6-month mortality after stroke at population level were also found. These results need to be confirmed and further investigated through a more robust information framework.</p
Air temperature-related human health outcomes: Current impact and estimations of future risks in Central Italy
n/
SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all-cause mortality, in Caucasians with type 2 diabetes: A 13-year observational study
Aims SIRT1 exerts effects on ageing and lifespan, as well cardiovascular (CV) disease risk. SIRT1 gene is very polymorph with a few tagging single nucleotide polymorphisms (SNPs) so far identified. Some SNPs, including rs7896005, were associated with type 2 diabetes (T2DM). We aimed to ascertain whether this SNP may be associated with CV disease at baseline as well with these same outcomes and all-cause mortality over a 13-year follow-up. Materials and Methods Genotypes of SIRT1 gene were determined using TaqMan SNP assay. Results Out of 905 T2DM, 9.1% had the AA genotype, 43.2% the AG, and 47.7% the GG. Hardy-Weinberg Equilibrium was met (minor allele frequency 0.306; p = 0.8899). At baseline, there was no difference across genotypes for sex, age, diabetes duration, CV risk factors, treatments, and microangiopathy. Major CV outcomes, myocardial infarction (MI), any coronary heart disease (CHD), and peripheral artery disease (PAD) were more frequent in GG than in AA/AG (p from 0.013 to 0.027), with no association with cerebrovascular events. By fully adjusted regression, GG remained independently related to major CV outcomes, MI, CHD, and PAD. Over follow-up, we recorded 258 major CV events (28.5%; AA/AG 25.2%, GG 32.2%; p = 0.014) with an adjusted hazard ratio (HR) of GG versus AA/AG of 1.296 (95% CI 1.007-1.668, p = 0.044); 169 coronary events (18.7%; AA/AG 15.4%, GG 22.2%; p = 0.006) with HR 1.522 (1.113-2.080, p = 0.008); 79 (8.7%) hospitalisation for heart failure (AA/AG 7.0%, GG 10.6%; p = 0.045) and HR 1.457 (0.919-2.309, p = 0.109); 36 PAD (4.0%; AA/AG 2.3%, GG 5.8%; p = 0.007) with HR 2.225 (1.057-4.684, p = 0.035). No association was found with cerebrovascular events, end stage renal disease, and all-cause mortality. Conclusions The rs7896005 SNP of SIRT1 might play a role in cardiovascular disease, mainly CHD risk in T2DM. Results call for larger association studies as well as studies to ascertain mechanisms by which this variant confers increased risk
- …